Drug Therapy

1. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.

Author
Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y;
Institution
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan. masikeda@ncc.go.jp
Journal
Oncology. 2007;72(3-4):188-93. Epub 2007 Dec 20.
Abstract URL
Click here to view abstract

2. Capecitabine for treatment of advanced hepatocellular carcinoma.

Author
von Delius S; Lersch C; Mayr M; Stock K; Schulte-Frohlinde E; Schmid RM; Eckel F;
Institution
Department of Internal Medicine II, Technical University of Munich, Klinikum rechts der Isar Munich, Germany. stefan_ruckert@yahoo.de
Journal
Hepatogastroenterology. 2007 Dec;54(80):2310-4.
Abstract URL
Click here to view abstract

3. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.

Author
Kudo M; Sakaguchi Y; Chung H; Hatanaka K; Hagiwara S; Ishikawa E; Takahashi S; Kitai S; Inoue T; Minami Y; Ueshima K;
Institution
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
Journal
Oncology. 2007;72 Suppl 1:132-8. Epub 2007 Dec 13.
Abstract URL
Click here to view abstract

4. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.

Author
Zhu AX;
Institution
Tucker Gosnell Center for Gastrointestinal Cancers, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA. azhu@partners.org
Journal
Cancer. 2008 Jan 15;112(2):250-9.
Abstract URL
Click here to view abstract

5. Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma.

Author
Yau T; Chan P; Wong H; Ng KK; Chok SH; Cheung TT; Lam V; Epstein RJ; Fan ST; Poon RT;
Institution
Department of Medicine, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong, China.
Journal
Oncology. 2007;72 Suppl 1:67-71. Epub 2007 Dec 13.
Abstract URL
Click here to view abstract

6. Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.

Author
Bernal E; Montero JL; Delgado M; Fraga E; Costan G; Barrera P; Lopez-Vallejos P; Solorzano G; Rufian S; Briceno J; Padillo J; Lopez-Cillero P; Marchal T; Muntane J; de la Mata M;
Institution
Liver Transplant Unit, Reina Sofia University Hospital, Cordoba, Spain.
Journal
Transplant Proc. 2006 Oct;38(8):2495-8.
Abstract URL
Click here to view abstract

7. Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha.

Author
Kurokohchi K; Takaguchi K; Kita K; Masaki T; Kuriyama S;
Institution
Third Department of Internal Medicine, Kagawa University School of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.
Journal
World J Gastroenterol. 2005 Sep 14;11(34):5401-3.
Abstract URL
Click here to view abstract

8. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.

Author
Ota H; Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Nakamura M; Damdinsuren B; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M;
Institution
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka E-2, Suita, Osaka 565-0871, Japan.
Journal
Br J Cancer. 2005 Sep 5;93(5):557-64.
Abstract URL
Click here to view abstract

9. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.

Author
Plentz RR; Tillmann HL; Kubicka S; Bleck JS; Gebel M; Manns MP; Rudolph KL;
Institution
Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Germany.
Journal
J Gastroenterol Hepatol. 2005 Sep;20(9):1422-8.
Abstract URL
Click here to view abstract

10. Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.

Author
Schwartz JD; Sung M; Schwartz M; Lehrer D; Mandeli J; Liebes L; Goldenberg A; Volm M;
Institution
Hematology-Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA. jonathan.schwartz@mssm.edu
Journal
Oncologist. 2005 Oct;10(9):718-27.
Abstract URL
Click here to view abstract

11. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.

Author
Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC; Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC;
Institution
Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, 660 S, Euclid Avenue, St Louis, MO 63110, USA.
Journal
J Am Coll Surg. 2006 Oct;203(4):411-20. Epub 2006 Aug 17.
Abstract URL
Click here to view abstract